Literature DB >> 17340632

The DNA topoisomerase IIbeta binding protein 1 (TopBP1) interacts with poly (ADP-ribose) polymerase (PARP-1).

Yvonne Wollmann1, Uta Schmidt, Gerhard D Wieland, Peter F Zipfel, Hans-Peter Saluz, Frank Hänel.   

Abstract

We investigated the physical association of the DNA topoisomerase IIbeta binding protein 1 (TopBP1), involved in DNA replication and repair but also in regulation of apoptosis, with poly(ADP-ribose) polymerase-1 (PARP-1). This enzyme plays a crucial role in DNA repair and interacts with many DNA replication/repair factors. It was shown that the sixth BRCA1 C-terminal (BRCT) domain of TopBP1 interacts with a protein fragment of PARP-1 in vitro containing the DNA-binding and the automodification domains. More significantly, the in vivo interaction of endogenous TopBP1 and PARP-1 proteins could be shown in HeLa-S3 cells by co-immunoprecipitation. TopBP1 and PARP-1 are localized within overlapping regions in the nucleus of HeLa-S3 cells as shown by immunofluorescence. Exposure to UVB light slightly enhanced the interaction between both proteins. Furthermore, TopBP1 was detected in nuclear regions where poly(ADP-ribose) (PAR) synthesis takes place and is ADP-ribosylated by PARP-1. Finally, cellular (ADP-ribosyl)ating activity impairs binding of TopBP1 to Myc-interacting zinc finger protein-1 (Miz-1). The results indicate an influence of post-translational modifications of TopBP1 on its function during DNA repair.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17340632     DOI: 10.1002/jcb.21292

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  9 in total

1.  Molecular basis of BACH1/FANCJ recognition by TopBP1 in DNA replication checkpoint control.

Authors:  Charles Chung Yun Leung; Zihua Gong; Junjie Chen; J N Mark Glover
Journal:  J Biol Chem       Date:  2010-12-02       Impact factor: 5.157

Review 2.  BRCT domains: easy as one, two, three.

Authors:  Charles Chung Yun Leung; J N Mark Glover
Journal:  Cell Cycle       Date:  2011-08-01       Impact factor: 4.534

3.  Sipl1 and Rbck1 are novel Eya1-binding proteins with a role in craniofacial development.

Authors:  Kathrin Landgraf; Frank Bollig; Mark-Oliver Trowe; Birgit Besenbeck; Christina Ebert; Dagmar Kruspe; Andreas Kispert; Frank Hänel; Christoph Englert
Journal:  Mol Cell Biol       Date:  2010-10-18       Impact factor: 4.272

4.  Insights from the crystal structure of the sixth BRCT domain of topoisomerase IIbeta binding protein 1.

Authors:  Charles Chung Yun Leung; Elizabeth Kellogg; Anja Kuhnert; Frank Hänel; David Baker; J N Mark Glover
Journal:  Protein Sci       Date:  2010-01       Impact factor: 6.725

5.  The N-terminus of the human RecQL4 helicase is a homeodomain-like DNA interaction motif.

Authors:  Oliver Ohlenschläger; Anja Kuhnert; Annerose Schneider; Sebastian Haumann; Peter Bellstedt; Heidi Keller; Hans-Peter Saluz; Peter Hortschansky; Frank Hänel; Frank Grosse; Matthias Görlach; Helmut Pospiech
Journal:  Nucleic Acids Res       Date:  2012-06-22       Impact factor: 16.971

6.  Functional interaction between type III-secreted protein IncA of Chlamydophila psittaci and human G3BP1.

Authors:  Nicole Borth; Katrin Litsche; Claudia Franke; Konrad Sachse; Hans Peter Saluz; Frank Hänel
Journal:  PLoS One       Date:  2011-01-31       Impact factor: 3.240

7.  Structural studies of the PARP-1 BRCT domain.

Authors:  Paul A Loeffler; Matthew J Cuneo; Geoffrey A Mueller; Eugene F DeRose; Scott A Gabel; Robert E London
Journal:  BMC Struct Biol       Date:  2011-10-03

8.  Structure and function of the Rad9-binding region of the DNA-damage checkpoint adaptor TopBP1.

Authors:  Mathieu Rappas; Antony W Oliver; Laurence H Pearl
Journal:  Nucleic Acids Res       Date:  2010-08-19       Impact factor: 16.971

Review 9.  Phosphorylation-dependent assembly of DNA damage response systems and the central roles of TOPBP1.

Authors:  Matthew Day; Antony W Oliver; Laurence H Pearl
Journal:  DNA Repair (Amst)       Date:  2021-09-29
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.